News
LEN is the first long-acting PrEP product that requires only two injections per year, offering an appealing alternative to ...
The World Health Organization (WHO) has recommended the global use of injectable lenacapavir (LEN) twice a year to provide near-total ...
U.N. health officials have estimated that more than 14 million children did not receive a single vaccine last year.
WHO, UNICEF warn of rising immunization gaps as nearly 20 million infants missed vaccination in 2024
The World Health Organization (WHO) and UNICEF have raised the alarm over widening immunization gaps globally, warning that millions of ...
India's youth face mental health crisis, impacting the nation's future; destigmatize help-seeking and strengthen support ...
The 78th World Health Assembly in Geneva this May marked a turning point in global health diplomacy. For the first time since ...
A new report released by the World Health Organization (WHO) and the UN Children’s Fund (UNICEF) reveals that an estimated 14 ...
The World Health Organization now recommends lenacapavir, a twice-yearly injectable HIV prevention drug, especially for high-risk groups. This endorse ...
A breakthrough HIV drug that only needs to be injected twice a year to offer near-total protection from the virus and ...
The World Health Organization on Monday recommended Gilead's lenacapavir, a twice-yearly injection, as a tool to prevent HIV infection.
The World Health Organization (WHO) has officially recommended the global rollout of injectable lenacapavir (LEN), a ...
An estimated 14.3 million children globally remain unvaccinated and vulnerable to vaccine-preventable illnesses – meaning ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results